In recent years,with the rapid development of precision medicine and the deepening of research on tumor-related molecular markers,the detection and application of colorectal cancer(CRC)-related molecular markers have become an important part of our clinical practice.In the treatment of CRC,different molecular subtypes have different treatment responses and prognosis.This review aims to summarize the treatment progress of different molecular subtypes of metastatic colorectal cancer(mCRC)and its relationship with clinical treatment and prognosis,so as to provide theoretical basis and practical guidance for individualized treatment.
维普
万方数据